A comprehensive review on the role of co-signaling receptors and Treg homeostasis in autoimmunity and tumor immunity

T Cells

Cancer immunotherapy with check point inhibitor can cause autoimmune adverse events due to loss of Treg homeostasis

Semin Cancer Biol.

Kumar P, Saini S, Prabhakar BS

doi: 10.1016/j.semcancer.

ImmunotherapyT Cells

Balancing cancer immunotherapy and immune-related adverse events: The emerging role of regulatory T cells

J Autoimmun.

Alissafi T, Hatzioannou A, Legaki AI, Varveri A, Verginis P

doi: 10.1016/j.jaut.2019.102310.

Autoimmune Disease

The pivotal role of CD69 in autoimmunity

J Autoimmun.

Gorabi AM, Hajighasemi S, Kiaie N, Gheibi Hayat SM, Jamialahmadi T, Johnston TP, Sahebkar A

doi: 10.1016/j.jaut.2020.102453.

Immunomodulation

Primary immunodeficiency and autoimmunity: A comprehensive review

J Autoimmun.

Amaya-Uribe L, Rojas M, Azizi G, Anaya JM, Gershwin ME

doi: 10.1016/j.jaut.2019.01.011.

T Cell Expression of C5a Receptor 2 Augments Murine Regulatory T Cell (TREG) Generation and TREG-Dependent Cardiac Allograft Survival

J Immunol.

A Verghese D, Demir M, Chun N, Fribourg M, Cravedi P, Llaudo I, Woodruff TM, Yadav P, Lira SA, Medof ME, Heeger PS

doi: 10.4049/jimmunol.1701638.

T Cells

TIGIT⁺ A2Ar-Dependent anti-uveitic Treg cells are a novel subset of Tregs associated with resolution of autoimmune uveitis

J Autoimmun.

Muhammad F, Wang D, McDonald T, Walsh M, Drenen K, Montieth A, Foster CS, Lee DJ

doi: 10.1016/j.jaut.2020.102441.

T Cells

Modulating the wayward T cell: New horizons with immune checkpoint inhibitor treatments in autoimmunity, transplant, and cancer

J Autoimmun

Calabrese LH, Caporali R, Blank CU, Kirk AD

doi: 10.1016/j.jaut.2020.102546

Autoimmune Disease

Innate immunity as the trigger of systemic autoimmune diseases

J Autoimmun.

Saferding V, Blüml S

doi: 10.1016/j.jaut.2019.102382.

Demodex mites modulate sebocyte immune reaction: Possible role in the pathogenesis of rosacea

Br J Dermatol.

Lacey N, Russell-Hallinan A, Zouboulis CC, Powell FC

doi: 10.1111/bjd.16540.

Related content

Cancer immunotherapy with check point inhibitor can cause autoimmune adverse events due to loss of Treg homeostasis

Balancing cancer immunotherapy and immune-related adverse events: The emerging role of regulatory T cells

The pivotal role of CD69 in autoimmunity

Primary immunodeficiency and autoimmunity: A comprehensive review

T Cell Expression of C5a Receptor 2 Augments Murine Regulatory T Cell (TREG) Generation and TREG-Dependent Cardiac Allograft Survival

TIGIT+ A2Ar-Dependent anti-uveitic Treg cells are a novel subset of Tregs associated with resolution of autoimmune uveitis

Modulating the wayward T cell: New horizons with immune checkpoint inhibitor treatments in autoimmunity, transplant, and cancer

Innate immunity as the trigger of systemic autoimmune diseases

Demodex mites modulate sebocyte immune reaction: Possible role in the pathogenesis of rosacea

TIGIT⁺ A2Ar-Dependent anti-uveitic Treg cells are a novel subset of Tregs associated with resolution of autoimmune uveitis